Literature DB >> 27151399

Shift of Macrophage Phenotype Due to Cartilage Oligomeric Matrix Protein Deficiency Drives Atherosclerotic Calcification.

Yi Fu1, Cheng Gao1, Ying Liang1, Meili Wang1, Yaqian Huang1, Wei Ma1, Tuoyi Li1, Yiting Jia1, Fang Yu1, Wanlin Zhu1, Qinghua Cui1, Yanhui Li1, Qingbo Xu1, Xian Wang1, Wei Kong2.   

Abstract

RATIONALE: Intimal calcification is highly correlated with atherosclerotic plaque burden, but the underlying mechanism is poorly understood. We recently reported that cartilage oligomeric matrix protein (COMP), a component of vascular extracellular matrix, is an endogenous inhibitor of vascular smooth muscle cell calcification.
OBJECTIVE: To investigate whether COMP affects atherosclerotic calcification. METHODS AND
RESULTS: ApoE(-/-)COMP(-/-) mice fed with chow diet for 12 months manifested more extensive atherosclerotic calcification in the innominate arteries than did ApoE(-/-) mice. To investigate which origins of COMP contributed to atherosclerotic calcification, bone marrow transplantation was performed between ApoE(-/-) and ApoE(-/-)COMP(-/-) mice. Enhanced calcification was observed in mice transplanted with ApoE(-/-)COMP(-/-) bone marrow compared with mice transplanted with ApoE(-/-) bone marrow, indicating that bone marrow-derived COMP may play a critical role in atherosclerotic calcification. Furthermore, microarray profiling of wild-type and COMP(-/-) macrophages revealed that COMP-deficient macrophages exerted atherogenic and osteogenic characters. Integrin β3 protein was attenuated in COMP(-/-) macrophages, and overexpression of integrin β3 inhibited the shift of macrophage phenotypes by COMP deficiency. Furthermore, adeno-associated virus 2-integrin β3 infection attenuated atherosclerotic calcification in ApoE(-/-)COMP(-/-) mice. Mechanistically, COMP bound directly to β-tail domain of integrin β3 via its C-terminus, and blocking of the COMP-integrin β3 association by β-tail domain mimicked the COMP deficiency-induced shift in macrophage phenotypes. Similar to COMP deficiency in mice, transduction of adeno-associated virus 2-β-tail domain enhanced atherosclerotic calcification in ApoE(-/-) mice.
CONCLUSIONS: These results reveal that COMP deficiency acted via integrin β3 to drive macrophages toward the atherogenic and osteogenic phenotype and thereby aggravate atherosclerotic calcification.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; cartilage oligomeric matrix protein; extracellular matrix; macrophages; phenotype; vascular calcification

Mesh:

Substances:

Year:  2016        PMID: 27151399     DOI: 10.1161/CIRCRESAHA.115.308021

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  19 in total

1.  COMP-lex Mechanics: Matricrine Signaling.

Authors:  Yin Tintut; Linda L Demer
Journal:  Circ Res       Date:  2016-07-08       Impact factor: 17.367

2.  CircHIPK3 Regulates Vascular Smooth Muscle Cell Calcification Via the miR-106a-5p/MFN2 Axis.

Authors:  Wen-Bo Zhang; You-Fei Qi; Zhan-Xiang Xiao; Hao Chen; Sa-Hua Liu; Zhen-Zhen Li; Zhao-Fan Zeng; Hong-Fei Wu
Journal:  J Cardiovasc Transl Res       Date:  2022-04-25       Impact factor: 4.132

3.  Circular RNA Cdyl promotes abdominal aortic aneurysm formation by inducing M1 macrophage polarization and M1-type inflammation.

Authors:  Haoyu Song; Yang Yang; Yili Sun; Guoquan Wei; Hao Zheng; Yijin Chen; Donghua Cai; Chuling Li; Yusheng Ma; Zhongqiu Lin; Xiaoran Shi; Wangjun Liao; Yulin Liao; Lintao Zhong; Jianping Bin
Journal:  Mol Ther       Date:  2021-09-20       Impact factor: 11.454

Review 4.  Histone Lysine Methylation Modification and Its Role in Vascular Calcification.

Authors:  Ye-Chi Cao; Su-Kang Shan; Bei Guo; Chang-Chun Li; Fu-Xing-Zi Li; Ming-Hui Zheng; Qiu-Shuang Xu; Yi Wang; Li-Min Lei; Ke-Xin Tang; Wen-Lu Ou-Yang; Jia-Yue Duan; Yun-Yun Wu; Muhammad Hasnain Ehsan Ullah; Zhi-Ang Zhou; Feng Xu; Xiao Lin; Feng Wu; Xiao-Bo Liao; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

5.  Calcification in atherosclerotic lesions.

Authors:  Hong Lu; Mary Sheppard; Alan Daugherty
Journal:  Curr Opin Lipidol       Date:  2016-10       Impact factor: 4.776

6.  COMP-prohibitin 2 interaction maintains mitochondrial homeostasis and controls smooth muscle cell identity.

Authors:  Yiting Jia; Meili Wang; Chenfeng Mao; Fang Yu; Yingbao Wang; Rui Xiao; Changtao Jiang; Lemin Zheng; Qingbo Xu; Ming Zheng; Yi Fu; Qinghua Hu; Wei Kong
Journal:  Cell Death Dis       Date:  2018-06-04       Impact factor: 8.469

7.  Altered serum level of cartilage oligomeric matrix protein and its association with coronary calcification in patients with coronary heart disease.

Authors:  Fang-Fang Wang; Lahati Ha; Hai-Yi Yu; Lin Mi; Jiang-Li Han; Wei Gao
Journal:  J Geriatr Cardiol       Date:  2017-02       Impact factor: 3.327

Review 8.  Role of Macrophages in the Progression and Regression of Vascular Calcification.

Authors:  Yalan Li; Zhen Sun; Lili Zhang; Jinchuan Yan; Chen Shao; Lele Jing; Lihua Li; Zhongqun Wang
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

9.  Cartilage oligomeric matrix protein is an endogenous β-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury.

Authors:  Yi Fu; Yaqian Huang; Zhao Yang; Yufei Chen; Jingang Zheng; Chenfeng Mao; Zhiqing Li; Zhixin Liu; Bing Yu; Tuoyi Li; Meili Wang; Chanjuan Xu; Yiwei Zhou; Guizhen Zhao; Yiting Jia; Wei Guo; Xin Jia; Tao Zhang; Li Li; Ziyi Liu; Shengchao Guo; Mingliang Ma; Heng Zhang; Bo Liu; Junbao Du; Wengong Wang; Chaoshu Tang; Pei Gao; Qingbo Xu; Xian Wang; Jianfeng Liu; Jinpeng Sun; Wei Kong
Journal:  Cell Res       Date:  2021-01-28       Impact factor: 25.617

10.  Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis.

Authors:  Vijayakrishna Kolur; Basavaraj Vastrad; Chanabasayya Vastrad; Shivakumar Kotturshetti; Anandkumar Tengli
Journal:  BMC Cardiovasc Disord       Date:  2021-07-04       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.